Conus Venom Peptide Pharmacology
Richard J. Lewis(AstraZeneca (Netherlands)), MacDonald J. Christie(The University of Sydney), Irina Vetter(Centre National de la Recherche Scientifique), Sébastien Dutertre(École Nationale Supérieure de Chimie de Montpellier)
Cited by 422
Related Papers
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
|Nature Medicine|2015|2.8k
Methods Used to Evaluate Pain Behaviors in Rodents
|Frontiers in Molecular Neuroscience|2017|1.3k
Cloning and expression of a rat D2 dopamine receptor cDNA
|Nature|1988|1.1k
Therapeutic potential of venom peptides
|Nature Reviews Drug Discovery|2003|786
Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
|Frontiers in Molecular Neuroscience|2017|654